AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

OTCMKTS:MDCLMedicine Man Technologies Stock Price, Forecast & News

$1.82
-0.07 (-3.70 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.82
Now: $1.82
$1.91
50-Day Range
$1.30
MA: $1.78
$2.00
52-Week Range
$1.05
Now: $1.82
$4.05
Volume110,694 shs
Average Volume84,948 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medicine Man Technologies, Inc. provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Business Services
Sub-IndustryCannabis
SectorIndustrials
Current SymbolOTCMKTS:MDCL
Previous SymbolNASDAQ:MDCL
CUSIPN/A
Phone+1-303-3710387

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees25
Next Earnings DateN/A
OptionableNot Optionable

Receive MDCL News and Ratings via Email

Sign-up to receive the latest news and ratings for MDCL and its competitors with MarketBeat's FREE daily newsletter.

Medicine Man Technologies (OTCMKTS:MDCL) Frequently Asked Questions

How has Medicine Man Technologies' stock been impacted by COVID-19 (Coronavirus)?

Medicine Man Technologies' stock was trading at $1.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDCL stock has increased by 11.0% and is now trading at $1.82. View which stocks have been most impacted by Coronavirus.

Has Medicine Man Technologies been receiving favorable news coverage?

Media headlines about MDCL stock have been trending negative on Wednesday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medicine Man Technologies earned a news impact score of -2.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutMedicine Man Technologies.

Who are some of Medicine Man Technologies' key competitors?

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Canopy Growth (CGC), Curaleaf (CURLF), Aurora Cannabis (ACB), Trulieve Cannabis (TCNNF), Charlotte's Web (CWBHF), KushCo (KSHB), Green Thumb Industries (GTBIF), Innovative Industrial Properties (IIPR), OrganiGram (OGI) and GrowGeneration (GRWG).

Who are Medicine Man Technologies' key executives?

Medicine Man Technologies' management team includes the following people:
  • Mr. Paul D. Dickman, Chairman, Corp. Sec. & Interim CFO (Age 39)
  • Mr. Andrew Williams, Co-Founder, Director & CEO (Age 50)
  • Mr. Joshua Haupt, Chief Revenue Officer (Age 32)
  • Mr. Joseph P. Puglise, COO & Director (Age 49)
  • Mr. James S. Toreson, Consultant (Age 77)

What is Medicine Man Technologies' stock symbol?

Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "MDCL."

How do I buy shares of Medicine Man Technologies?

Shares of MDCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medicine Man Technologies' stock price today?

One share of MDCL stock can currently be purchased for approximately $1.82.

What is Medicine Man Technologies' official website?

The official website for Medicine Man Technologies is medicinemantechnologies.com.

How can I contact Medicine Man Technologies?

Medicine Man Technologies' mailing address is 4880 Havana St, DENVER, CO 80239-2402, United States. The company can be reached via phone at +1-303-3710387.

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.